Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Pictilisib Formulations in Healthy Subjects
NCT02092831Phase 1Completed
- Sponsor
- Genentech
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of pictilisib in solid tumor (4 arms), sponsored by Genentech. Primary endpoints: Area under the concentration-time curve at 25 days, Maximum plasma concentration at 25 days and 1 more. Started Apr 2014; status: completed.
02
Drugs
pictilisib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT02092831.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02092831.